Published in Arch Otolaryngol on December 01, 1982
Linkage of otosclerosis to a third locus (OTSC3) on human chromosome 6p21.3-22.3. J Med Genet (2002) 0.89
An overview of the etiology of otosclerosis. Eur Arch Otorhinolaryngol (2008) 0.85
HLA associations in otosclerosis in Japanese patients. Eur Arch Otorhinolaryngol (1996) 0.75
Hairy cell leukemia: splenectomy after alpha 2b-interferon therapy. Blood (1991) 2.01
Infralimbic cortex activation increases c-Fos expression in intercalated neurons of the amygdala. Neuroscience (2005) 1.91
Hairy-cell leukaemia-associated polyarthritis: a report of two cases. Br J Rheumatol (1991) 1.39
On the familial predisposition to favism. Am J Hum Genet (1966) 1.29
Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Ann Oncol (2010) 1.16
Peptide analysis of the inclusions of erythroid cells in beta-thalassemia. Biochim Biophys Acta (1966) 1.11
HLA-B27 frequency in Greek patients with acute anterior uveitis. Br J Ophthalmol (1977) 1.07
Clinical approach to lymphadenopathy. Semin Oncol (1993) 1.04
Ectopic production of human chorionic gonadotropin (hCG) by neoplasms: the value of measurements of immunoreactive hCG in the urine as a screening procedure. Cancer (1980) 0.99
Identification of slow-moving haemoglobins in haemoglobin H disease from different racial groups. Lancet (1972) 0.96
Multiple myeloma associated with autoimmune hemolytic anemia. Haematologica (1994) 0.95
F-Thalassemia. A study of thirty-one families with simple heterozygotes and combinations of F-Thalassemia with A2-Thalassemia. Am J Med (1969) 0.94
Prenatal diagnosis of thalassemia major in Greece: evaluation of the first large series of attempts. Ann N Y Acad Sci (1980) 0.94
'Silent' beta-thalassaemia caused by a 'silent' beta-chain mutant: the pathogenesis of a syndrome of thalassaemia intermedia. Br J Haematol (1982) 0.93
Pseudoxanthoma elasticum-like skin lesions and angioid streaks in beta-thalassemia. Am J Hematol (1992) 0.92
HLA antigens and Adamantiades-Behçet's disease (A-BD) in Greeks. Clin Exp Rheumatol (1988) 0.89
Structural study of hemoglobin Knossos, beta 27 (B9) Ala leads to Ser. A new abnormal hemoglobin present as a silent beta-thalassemia. FEBS Lett (1982) 0.87
Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study. Br J Cancer (2004) 0.87
The origin of the sickle mutation in Greece; evidence from beta S globin gene cluster polymorphisms. Hemoglobin (1991) 0.86
Intraerythroblastic instability of hemoglobin beta-4 (Hgb H). Blood (1968) 0.86
The pattern of hemoglobin precipitation in thalassemia and its significance. Ann N Y Acad Sci (1969) 0.86
B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit. Cancer (1987) 0.85
Ectopic thyroid gland in the submandibular region. J Laryngol Otol (1980) 0.85
Survey of breakfast and infant cereals for aflatoxins B1, B2, G1 and G2. Food Addit Contam (2006) 0.84
HLA antigens in diabetics with calcified shoulder periarthritis (CSP). Clin Exp Rheumatol (1987) 0.84
Tuberculosis associated hemophagocytic syndrome complicated with severe bone marrow failure and disseminated intravascular coagulation. Nouv Rev Fr Hematol (1992) 0.84
Prenatal diagnosis of thalassemia and Hb S syndromes in Greece: an evaluation of 1500 cases. Ann N Y Acad Sci (1985) 0.83
HLA antigens and multiple sclerosis in Greeks. J Neurol Neurosurg Psychiatry (1984) 0.83
HLA and pemphigus. Br J Dermatol (1979) 0.83
Surveys of rice sold in Canada for aflatoxins, ochratoxin A and fumonisins. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2011) 0.83
Anterior pituitary function in the Prader-Labhart-Willi (PLW) syndrome. J Clin Endocrinol Metab (1974) 0.82
Application of isotope dilution mass spectrometry: determination of ochratoxin A in the Canadian Total Diet Study. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2011) 0.82
Lactate dehydrogenase isoenzyme pattern in sera of patients with malignant diseases. Clin Chem (1989) 0.81
Low incidence of acute myocardial infarction in beta-thalassaemia trait carriers. Haematologia (Budap) (1995) 0.81
Angio-immunoblastic lymphadenopathy terminating as Hodgkin's disease. Cancer (1977) 0.81
Extramedullary blast crisis in chronic myelogenous leukemia presenting with manifestations of cauda equina syndrome. Haematologica (1988) 0.81
Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit. Ann Hematol (2001) 0.80
Salivary amylase activity in diabetes mellitus. Panminerva Med (1979) 0.79
Ochratoxin A in wine and grape juice sold in Canada. Food Addit Contam (2004) 0.79
The beta-delta thalassemias. Ann N Y Acad Sci (1969) 0.79
HLA antigens and congenital dislocation of the hip. Tissue Antigens (1983) 0.79
Hemoglobin Knossos: a clinical, laboratory, and epidemiological study. Am J Hematol (1986) 0.79
Survey of aflatoxins in beer sold in Canada. Food Addit Contam (2005) 0.79
A case of spinal cord compression by extramedullary haemopoiesis in a thalassaemic patient: a putative role for hydroxyurea? Haematologica (1992) 0.79
Recurrent attacks of hemolytic uremic syndrome. Haematologia (Budap) (1991) 0.78
Proteolysis in thalassemia: studies with protease inhibitors. Ann N Y Acad Sci (1980) 0.78
Hemoglobins of early human embryonic development. Science (1966) 0.78
HLA-A1 probable association with Perthe's disease. Tissue Antigens (1982) 0.77
[Management of dental problems in the deaf child]. Stomatologia (Athenai) (1977) 0.77
Thalassemia control in Greece. Birth Defects Orig Artic Ser (1988) 0.77
Prenatal diagnosis of beta-thalassemia; the greek experience. Birth Defects Orig Artic Ser (1982) 0.77
Acute bone marrow aplasia associated with intravenous administration of deferoxamine (desferrioxamine). Drug Saf (1990) 0.76
Association between nasopharyngeal carcinoma and HLA antigens in Greeks. Panminerva Med (1984) 0.76
HLA antigens and asthma in Greeks. Respir Med (1996) 0.76
Fluorescent labelling of proteins of lymphocyte plasma membranes. J Immunol Methods (1979) 0.76
Alternate paclitaxel-gemcitabine and paclitaxel-vinorelbine biweekly administration in non-small cell lung cancer patients: a phase II study. Anticancer Res (2006) 0.76
Urinary beta-aminoisobutyric acid excretion in thalassaemia. J Clin Pathol (1969) 0.76
Sideroblastic anemia treated with immunosuppressive therapy. Blood (1974) 0.76
An investigation into the immunogenicity of various components of osteoarticular grafts. Br J Exp Pathol (1974) 0.76
HLA-A and -B antigens in chronic bronchitis. J Clin Epidemiol (1993) 0.76
Thalassaemia. Clinical and patho-physiological considerations. Trans R Soc Trop Med Hyg (1967) 0.76
Linkage of HLA with familiar vesicoureteral reflux and familial pelvic-ureteric junction obstruction. Tissue Antigens (1990) 0.75
Haemoglobin E and alpha-thalassaemia. Br Med J (1968) 0.75
[Genuine cholesteatomas of the petrous bone]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1972) 0.75
Beta-glucuronidase activity of lymph node imprints from malignant lymphomas and chronic lymphocytic leukaemia. J Clin Pathol (1977) 0.75
On the chemical abnormality of Hb "Alexandra", a fetal hemoglobin variant. Blood (1969) 0.75
HLA subtypes and meningococcal disease. Lancet (1989) 0.75
HLA typing in the Hong Kong Chest Service/British Medical Research Council Study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. Am Rev Respir Dis (1989) 0.75
Tracheal adenomas. Ear Nose Throat J (1978) 0.75
[Treatment of sudden deafness]. Minerva Otorinolaringol (1971) 0.75
[Deafness in diseases of the central nervous system and its treatment]. Minerva Otorinolaringol (1971) 0.75
Labyrinthine reflexive influences on blood pressure during stapedectomy. J Laryngol Otol (1975) 0.75
[Management of sudden deafness]. Ann Otolaryngol Chir Cervicofac (1971) 0.75
[Deafness in central nervous system diseases and their treatment]. Ann Otolaryngol Chir Cervicofac (1971) 0.75
[Oral surgery in cases of hemophilia]. Stomatologia (Athenai) (1972) 0.75
[Hearing loss and hyperthyroidism (author's transl)]. Arch Otorhinolaryngol (1978) 0.75
[The reconstructive use of bipedicled chest flap in cancer surgery of the neck (author's transl)]. Arch Otorhinolaryngol (1978) 0.75
[Myeloma globulin A in parotid saliva]. Stomatologia (Athenai) (1975) 0.75
[Nervous deafness as a complication of chronic otitis media. Prevention and treatment]. Minerva Otorinolaringol (1971) 0.75
[Surgical treatment of cancer of the base of the tongue]. Stomatologia (Athenai) (1982) 0.75
[Current views on the treatment of cancer of the maxillary sinus]. Stomatologia (Athenai) (1974) 0.75
57Co-bleomycin imaging study of tumors of the head and neck. Laryngoscope (1978) 0.75
[The effect of adenoid hypertrophy on the development of the maxillofacial system]. Stomatologia (Athenai) (1975) 0.75
Clinical significance of patterns of bone marrow involvement in chronic lymphocytic leukemia and small lymphocytic (well-differentiated) non-Hodgkin's lymphoma. Bibl Haematol (1984) 0.75
[Perception deafness caused by direct or indirect injuries. (Occupational deafness excluded). Treatment--long-term prognosis]. Minerva Otorinolaringol (1971) 0.75
Odontogenic ethmoiditis. Rhinology (1979) 0.75
[Prosthetic rehabiliation following hemignathectomy and orbital exentration]. Stomatologia (Athenai) (1975) 0.75
Granular cell myoblastoma of the larynx. J Laryngol Otol (1978) 0.75
[Respiratory function before and after total laryngectomy]. Ann Otolaryngol Chir Cervicofac (1972) 0.75
A schwannoma of the parotid gland. Report of a case. J Laryngol Otol (1978) 0.75